Non-invasive genetic test

PrenaTest® is a molecular genetic method that is able to examine the cell-free fetal DNA fragments circulating in the mother’s blood, determine their origin (that is, which chromosome they come from) and quantity. For instance, a fetus with Down syndrome (trisomy 21) sheds cell-free DNA with an extra 21st chromosome into the mother’s blood, which can be very effectively screened for using this new method.

Using PrenaTest® , trisomies 21, 18, and 13 (Down-, Edwards- and Patau syndromes) can be detected, as can sex chromosome abnormalities (Turner-, Klinefelter-, Jakob-, Triple X syndromes).

The effectiveness of this risk-free maternal blood test was determined by international clinical studies with a large number of patients. The molecular genetic testing method based on the new generation sequencing technology is close to 100% effective, based on the results of several clinical trials.

When PrenaTest® is performed:

The test can be performed at any time between the 9th (9+0) and 20th (19+6) week of pregnancy, but within this time frame, it is recommended to perform the test as early as possible.

PrenaTest® results:

The results of the test (depending on its effectiveness) indicate any abnormality that points to the presence of Down syndrome, and this numerical value is done using a bio-computer method, calculating a z-score. The expectant mother receives her PrenaTest® results within 8 working days.

PrenaTest® testing options:

PrenaTest® Basic (Down syndrome detection)

PrenaTest® Optimum (Down syndrome, Edwards syndrome, Patau syndrome detection)

PrenaTest® Plus (Down syndrome, Edwards syndrome, Patau syndrome, sex chromosome abnormalities detection)

Doctors: 
Elekes Tibor

Tibor Elekes, M.D.

Monday: 
Tuesday: 
8:00 - 18:00
Wednesday: 
8:00 - 17:30
Thursday: 
Friday: 
8:00 - 12:30
Saturday: 
Csermely Gyula

Gyula Csermely, M.D., Ph.D.

Monday: 
8:00 - 15:00
Tuesday: 
8:00 - 15:00
Wednesday: 
8:00 - 12:00
Thursday: 
8:00 - 15:00
Friday: 
Saturday: